| Laboratory of Immunology, Research Institute of Endocrinology, Prague, Czech Republic |
1989-1991 |
| Institute of Biochemistry and Medical chemistry, University of Bari, Bari, Italy |
1993 |
| Institute of Physiology, ASCR, Prague, Czech Republic |
1991-1997 |
| Johns Hopkins University, Oncology Center, Baltimore, Maryland, USA, postdoctoral stay |
1997-2000 |
| Department of Pharmacology of Natural Products and Clinical Pharmacology, University Hospital of Ulm, Ulm, Germany, postdoctoral stay, habilitation |
2000-2005 |
| GEN-TREND s.r.o., Czech Republic, Research & Development Director |
2005-2008 |
| Protean s.r.o., Czech Republic, Research & Development Director, Ceo |
2008-present |
| Grant Agency of the Czech Republic: Regulation of expression and function of pyrogenic cytokines in somatic cells. |
1995-1997 |
| National Institute of Health, USA: Cloning and characterization of novel Kaposi’s sarcoma herpes virus-encoded interferon regulatory factors. |
1997-2000 |
| University of Ulm, Germany: Cloning and characterization of human homologue of viral interferon regulatory factor 2 (vIRF-2). |
2001-2003 |
| Deutsches Forschunggesellschaft (DFG), Germany: Characterization of virus-induced transcription factors and regulation of gene expression of the host cell. |
2002-2004 |
| Ministry of Industry and Trade of the Czech Republic, Project Impulse: Development and manufacture of new generation of molecular biological diagnostic kits for parallel "macroarray" detection of human pathogens. |
2004-2006 |
| German-Israeli Project Cooperation (DIP), The German Ministry for Education and Research (BMBF), Germany: The role of intracellular IL-1 alpha in health and disease: mechanisms of action and therapeutic applications. |
2005 |
Společnost Protean s.r.o. byla založena v roce 2008 za účelem výzkumu, vývoje a výroby moderních diagnostických prostředků na základě analýzy DNA a genového inženýrství.
